EQT AB (publ) (LON:0AAZ)
319.10
-4.63 (-1.43%)
At close: Nov 7, 2025
EQT AB Revenue
EQT AB had revenue of 1.27B EUR in the half year ending June 30, 2025, with 14.17% growth. This brings the company's revenue in the last twelve months to 2.69B, up 23.51% year-over-year. In the year 2024, EQT AB had annual revenue of 2.65B with 24.99% growth.
Revenue (ttm)
2.69B EUR
Revenue Growth
+23.51%
P/S Ratio
12.89
Revenue / Employee
1.39M EUR
Employees
1,937
Market Cap
29.77B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.65B | 530.30M | 24.99% |
| Dec 31, 2023 | 2.12B | 625.10M | 41.75% |
| Dec 31, 2022 | 1.50B | -98.70M | -6.18% |
| Dec 31, 2021 | 1.60B | 887.30M | 125.20% |
| Dec 31, 2020 | 708.70M | 144.80M | 25.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 1, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |